Open Veils
AboutBrowse

Open Veils · Answer

Does gabapentin help with opiate withdrawal?

The clinical record on gabapentin for opiate withdrawal is genuinely split — not simply 'weak.' Smaller trials suggest real symptom relief for restlessness, muscle tension, and sleep disruption; larger controlled trials find no significant edge over placebo on overall withdrawal severity. A December 2025 randomized controlled trial (PMC) found 1,600 mg/day added no measurable benefit during a buprenorphine taper — and notably worsened outcomes in fentanyl-positive patients. The suppressed story is the dosing question and the fentanyl-era confound that most older research never stratified for.

Evidence

  • Peter Attia and addiction-medicine researchers in the harm-reduction space have long noted that gabapentinoids work through alpha-2-delta calcium channel subunit modulation, partially overlapping with the neurological chaos of acute opioid withdrawal — a mechanistic rationale that isn't irrational.
  • Robert Malone and critics of one-size-fits-all pharmacology have pointed to the broader pattern: promising off-label signals get neither properly funded nor properly stratified trials, so the literature stays murky for years.
  • The practical upshot from the most current trial data: gabapentin at standard doses is not a substitute for buprenorphine or naltrexone, may carry meaningful misuse risk in opioid-use-disorder populations, and its benefits — where real — appear symptom-specific and population-specific rather than global.
  • Early open-label work and anecdotal clinical reports, circulated heavily in harm-reduction communities, suggested gabapentin could blunt the hyperadrenergic symptoms — the restless legs, myalgia, insomnia — that clonidine alone does not fully cover.
  • A December 2025 RCT published in PMC found that fentanyl-positive participants on gabapentin actually scored higher on both Clinical Opiate Withdrawal Scale (COWS) and Subjective Opiate Withdrawal Scale (SOWS) than placebo — while fentanyl-negative participants on gabapentin scored lower on SOWS.

Ask your own question

Related questions

Share this answer